Heska Corporation (NASDAQ: HSKA) seeks to enhance shareholder value through exceptional business practices and operational performance, strong governance, responsible reporting, and effective communication and engagement. Heska actively engages the public market with timely reporting, relevant presentations and events, and other important financial data and filings.
Heska Corporation (NASDAQ: HSKA) manufactures, develops and sells advanced veterinary diagnostic and specialty healthcare products through its two business segments: Core Companion Animal Health (“CCA”) and Other Vaccines and Pharmaceuticals (“OVP”). CCA segment includes Point of Care Laboratory testing instruments and consumables, primarily under a unique multi-year subscription model, digital imaging products, software and services, data services, allergy testing and immunotherapy, and single use offerings such as in-clinic diagnostic tests and heartworm preventive products. OVP segment includes private label vaccine and pharmaceutical production under third party agreements and channels, primarily for herd animal health.
- Heska Corporation First Quarter 2020 Earnings Call Webcast (May 7, 2020 11:00 AM ET)
- Heska 2020 Annual Meeting of Stockholders & VoteHeska 2020 Annual Meeting of Stockholders & Vote (April 8, 2020 11:00 AM ET)
- Heska Corporation to present at the Raymond James 41st Annual Institutional Investors ConferenceHeska Corporation to present at the Raymond James 41st Annual… (March 3, 2020 9:50 AM ET)
- Heska Fourth Quarter and Full Year 2019 Earnings Call WebcastHeska Fourth Quarter and Full Year 2019 Earnings Call Webcast (February 25, 2020 11:00 AM ET)
- J.P. Morgan Healthcare Conference Presentation38th Annual J.P. Morgan Healthcare Conference (January 15, 2020 6:00 PM ET)
Please fill out the form below to receive company press releases and other information via email when they occur.